What is it about?
The indications for Adaptive-Servoventilation (ASV) therapy and its benefits in clinical practice for patients with mixed or central sleep apnoea syndrome have not been well studied. The READ-ASV registry baseline data describes the underlying causes of the sleep disorder and the burden of symptoms (in terms of disease-specific quality of life and sleepiness) for patients who were eligible for a therapy with ASV.
Featured Image
Read the Original
This page is a summary of: Registry on the Treatment of Central and Complex Sleep-Disordered Breathing with Adaptive Servo-Ventilation (READ-ASV): protocol and cohort profile, ERJ Open Research, January 2023, European Respiratory Society (ERS),
DOI: 10.1183/23120541.00618-2022.
You can read the full text:
Contributors
The following have contributed to this page